Arca
Skip to content
Tools
Tools

SLC22A11: Solute carrier family 22 member 11

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

Antiporter that mediates the transport of conjugated steroids and other specific organic anions at the basal membrane of syncytiotrophoblast and at the apical membrane of proximal tubule epithelial cells, in exchange for anionic compounds.

  • Drugs that act on it: 1
  • Approved: 1
  • In phases 1 to 3: 0
  • Sponsors: 1

Who Is On It, and How Far Along

Every drug ChEMBL records acting on SLC22A11, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule

Approved1

  • Probenecid

Phase 30

    Phase 20

      Phase 10

        The Landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
        DrugFurthest stageSponsorModalityActionMechanismOpen trialsWarnings
        ProbenecidApprovedMerck & Co. (MSD)Small moleculeInhibitorSolute carrier family 22 member 11 inhibitor9—

        Open Trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 8 in all, from ClinicalTrials.gov.
        A Study to Assess the Effects of Probenecid on the Pharmacokinetics of Mirdametinib and Its Metabolites in Healthy ParticipantsProbenecidPhase 1RecruitingMerck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany2026-09-25
        Drug-drug Interactions Studies of VC005 Tablets in Healthy Adult SubjectsProbenecidPhase 1Not yet recruitingJiangsu vcare pharmaceutical technology co., LTD2026-09-01
        Enhancing Amoxicillin Pharmacokinetics and Pharmacodynamics Parameters With Probenecid in Bone and Joint InfectionsProbenecidPhase 3Not yet recruitingAssistance Publique - Hôpitaux de Paris2026-08-13
        Therapeutics for Moderate and Severe DengueProbenecidPhase 3Not yet recruitingOxford University Clinical Research Unit, Vietnam2026-04-21
        Efficacy of Probenecid on Cluster Seizures During Anti Seizure Medication Withdrawal in Presurgical Focal Epilepsy Video-EEG MonitoringProbenecidPhase 2RecruitingFondation Ophtalmologique Adolphe de Rothschild2026-01-06
        Probenecid Administration for Alcohol Craving and ConsumptionProbenecidPhase 2RecruitingBrown University2025-08-12
        Pharmacokinetics of Sulopenem Etzadroxil Plus Probenecid in AdolescentsProbenecidPhase 1RecruitingIterum Therapeutics, International Limited2025-07-30
        Improvement of Reproductive Function in Men With Spinal Cord Injury (SCI)ProbenecidPhase 3RecruitingUniversity of Miami2023-06-15

        Diseases Most Associated With It

        Open Targets association score, 0 to 1; all associations
        Gout
        0.66
        Ocular hypotension
        0.34
        Neurodegenerative disease
        0.32
        Hypertensive disorder
        0.28
        Endothelial dysfunction
        0.26

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2073677, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-18. Gene name, function (UniProt Q9NSA0, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

        Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.